Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Lion's Head Global Partners
Street 1: 130 Buckingham Palace Rd
Street 2:
City: London
Province:
Post Code: SW1W 9SA
Country: United Kingdom of Great Britain and Northern Ireland
Phone: 02073400400
Organization Email: info@lhgp.com
Web Site: http://www.lhgp.com
Other Online Presence:

Focal Point Contact Information

Salutation: Ms
First Name: Marilia
Last Name: Martins
Title: NA
Email: marilia.martins@lhgp.com
Phone:  

Alternate Focal Point Contact Information

Salutation: NA
First Name: NA
Last Name: NA
Title:  
Email: NA
Phone:  

General Information

Board Constituency: Private sector
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
Lion’s Head is a specialized merchant bank based in London and Nairobi, focusing on emerging markets and Sub-Saharan Africa. We provide financial advisory services across a range of sectors, including agriculture, health care, education, financial intermediation and infrastructure.

In health we focus on infectious diseases, with investment activities in antimicrobial resistance more broadly and TB specifically. We continue to engage a range of investors, development finance institutions, industry and philanthropic partners in how to use finance and financial markets to support developmental outcomes including diseases like TB.
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Funding, including innovative and optimized approach to funding TB Care

Other Organization Information

Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
 
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
NA
 

Geographical Reach

Which country is your headquarters located in: United Kingdom of Great Britain and Northern Ireland
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Australia
Bangladesh
Belgium
Botswana
Brazil
Cambodia
China
Colombia
Cote d'Ivoire
El Salvador
Eswatini
Ethiopia
Gambia
Germany
Ghana
Honduras
India
Indonesia
Italy
Jordan
Kenya
Malawi
Mexico
Namibia
Netherlands
Nigeria
Norway
Rwanda
Saint Lucia
Senegal
South Africa
Sweden
Switzerland
United Kingdom of Great Britain and Northern Ireland
United States of America
Zimbabwe

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Chair of the UK's Global Antimicrobial Resistance Innovation Fund (GAMRIF) that deploys capital on behalf of the UK government into AMR. We are also working with large pharmaceutical partners on innovative finacing mechanisms to incentivise R&D in resistance breaking antibiotics.

New Diagnostics:
Strategic business advisor to a number of companies focused on novel TB diagnostics, including POC TB diagnosis and lower cost resistance mapping.

New TB Drugs:
Strategic advisor to small biotech developing novel drugs for TB.

New TB Vaccines:
Exploring investment opportunities in TB vaccine development and in alternative options for manufacturing scale up.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: April 21, 2017
Last updated: September 5, 2018